IBO Impact BioMedical, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

Impact BioMedical Inc (IBO) noyob patentlardan foydalangan holda onkologiya va viruslarga qarshi kurashish uchun diversifikatsiyalashgan biomeditsina yechimlarini ishlab chiqadi. Bozor qiymatining buxgalteriya qiymatiga nisbati asosiy aktivlarning ishonchliligini baholash imkonini beradi, bunda 2.92 darajasi joriy miqdorni aks ettiradi. Ishlab chiqilayotgan loyihalarning gumanitar maqomi barqaror operatsion asosni ta'minlaydi, portfel o'sishi va texnologiyalarni tijoratlashtirish esa strategik litsenziyalash sherikliklari orqali amalga oshiriladi.

Impact BioMedical Inc (IBO) - Bozor kapitallashuvining balans qiymatiga nisbati 17.09.2024dan 27.10.2026gacha

IBO (Impact BioMedical, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Impact BioMedical|IBO - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Impact BioMedical|IBO - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Impact BioMedical|IBO - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati impactbiomedinc.com|IBO - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Impact BioMedical Inc|IBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Impact BioMedical Inc|IBO - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Impact BioMedical
Kompaniyaning asosiy tahlili:IBO (Impact BioMedical)

Bozor qiymatining buxgalteriya qiymatiga nisbati biznesning bozor qiymati va uning sof aktivlari qiymati o'rtasidagi farqni o'lchaydi. Investorlar ushbu koeffitsiyentdan aktiv yuzaki ravishda arzon ko'ringanda "qiymat tuzoqlarini" aniqlash uchun foydalanadilar. Bozor qiymatining buxgalteriya qiymatiga nisbati koeffitsiyentining joriy dinamikasini tahlil qilish orqali kompaniya kapitaliga bozorning ishonchini baholash mumkin. Impact BioMedical Inc (IBO) uchun bu resurslarning ko'plab ishlanmalar bo'ylab tarqalganligi sababli juda muhimdir. Loyihalarning tijoratlashtirilishi muvaffaqiyatsiz tugashining yuqori xavfi balans hisobotining tizimli ravishda yomonlashishiga olib kelishi mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc (HLN)|kenvue.com (KVUE) - Sof aktivlarga nisbatan bozor kapitallashuvi|VRNA - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Jyong Biotech Limited|Bozor kapitallashuvining balans qiymatiga nisbati LGND|Bozor kapitallashuvining balans qiymatiga nisbati AMRX (Amneal Corp)|Bozor qiymatining balans qiymatiga nisbati Perrigo Company plc|alvotech.com - Balans qiymatiga nisbatan bozor qiymati|LQDA: Bozor qiymatining balans qiymatiga nisbati|GLPG - Kapitallashuvning sof aktivlarga nisbati|ANIP: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Afrezza|AMPH - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati PCRX|ARS Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Theravance Biopharma Inc TBPH|Kapitallashuvning sof aktivlarga nisbati Aquestive Pharma (AQST)|Bozor kapitallashuvining balans qiymatiga multiplikatori scPharmaceuticals, Inc. SCPH|Bozor kapitallashuvining balans qiymatiga nisbati Tectonic (TECX)|TNXP - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SXTC|EPRX (Eupraxia Pharmaceuticals Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BHST - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Invizyne|ORMP (Oramed Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ENTX (enterabio.com)|MindWalk Holdings Inc. - Bozor qiymatining balans qiymatiga nisbati|ABVC BioPharma Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Cumberland Pharma|QNTM - Sof aktivlarga nisbatan bozor kapitallashuvi|FGEN: Bozor kapitallashuvining balans qiymatiga nisbati|telomirpharma.com (TELO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RANI|Kapitallashuvning sof aktivlarga nisbati Synergy CHC Corporation (SNYR)|Kapitallashuvning sof aktivlarga nisbati Rallybio Corporation|Bozor kapitallashuvining balans qiymatiga multiplikatori lexariabioscience.com LEXX|Kapitallashuvning sof aktivlarga nisbati Pulmatrix, Inc.|Balans qiymatiga nisbatan bozor qiymati Pheton Holdings Limited PTHL|APM - Bozor kapitallashuvining balans qiymatiga nisbati|LYRA - Bozor qiymatining balans qiymatiga nisbati|tnfpharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|YCBD (cbdMD) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati PRFX (PainReform Ltd.)|Bozor qiymatining balans qiymatiga koeffitsiyenti CYTO|Bozor qiymatining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OptiNose Inc (OPTN)|PIRS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Procaps Group Corp PROC|Petros Pharmaceuticals (PTPI) - Bozor kapitallashuvining balans qiymatiga nisbati|QLI - Kapitallashuvning balans qiymatiga nisbati|ACELYRIN - Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor kapitallashuvi